An update of advanced nanoplatforms for Glioblastoma Multiforme Management

Glioblastoma multiforme (GBM) is a very aggressive and heterogeneous glioma. Currently, GBM is treated with a combination of surgery, radiotherapy, chemotherapy (e.g. temozol­amide) and Tumour Treating Fields. Unfortunately, the mean survival is still around 15 months. This poor prognosis is associa...

Full description

Bibliographic Details
Main Authors: Mariana Amaral, Nuno Cruz, Ana Rosa, Beatriz Nogueira, Diana Costa, Francisco Santos, Mariana Brazão, Pedro Policarpo, Rita Mateus, Yan Kobozev, Catarina Pinto Reis
Format: Article
Language:English
Published: IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund 2021-11-01
Series:EXCLI Journal : Experimental and Clinical Sciences
Subjects:
Online Access:https://www.excli.de/index.php/excli/article/view/4393